haku: @journal_id 631 / yhteensä: 215
viite: 38 / 215
| Tekijä: | Stolpe, M. |
| Otsikko: | Prioritäten für den globalen Aids-Fonds: eine ökonomische Analyse |
| Lehti: | Weltwirtschaft
2001 : 3, p. 305-314 |
| Asiasana: | Health economics |
| Kieli: | ger |
| Tiivistelmä: | The fight against Aids, one of the world's greatest challenges at the beginning of the 21st century, is not yet organized efficiently. Many of the infected cannot get the best currently known medicines because private monopolies protected by patents have encouraged the producers of these medicines to raise prices way above the variable unit costs of production. The best strategy in line with both short-term and long-term objectives in the fight against Aids relies on the free licensing of selected potent Aids-drugs and vaccines after their respective intellectual property rights have been acquired by the global Aids-fund (original in German). |
SCIMA